{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T03:21:22Z","timestamp":1780370482209,"version":"3.54.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-026-06792-y","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T19:49:51Z","timestamp":1771444191000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The role of microRNAs in Kawasaki disease: a systematic review"],"prefix":"10.1007","volume":"185","author":[{"given":"Grzegorz","family":"Procyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Ros\u00f3\u0142","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Lamparski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiktoria","family":"Modrzejewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zofia","family":"Wcis\u0142o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Procyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"G\u0105secka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo\u017cena","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"6792_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0140-6736(04)16814-1","volume":"364","author":"JC Burns","year":"2004","unstructured":"Burns JC, Glod\u00e9 MP (2004) Kawasaki syndrome. Lancet 364:533\u2013544","journal-title":"Lancet"},{"key":"6792_CR2","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle BW, Rowley AH, Newburger JW et al (2017) Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 135:e927\u2013e999","journal-title":"Circulation."},{"key":"6792_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jpeds.2020.05.034","volume":"225","author":"R Ae","year":"2020","unstructured":"Ae R, Makino N, Kosami K et al (2020) Epidemiology, treatments, and cardiac complications in patients with Kawasaki disease: the nationwide survey in Japan, 2017\u20132018. J Pediatr. 225:23-29.e22","journal-title":"J Pediatr."},{"key":"6792_CR4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/ped.13809","volume":"61","author":"N Makino","year":"2019","unstructured":"Makino N, Nakamura Y, Yashiro M et al (2019) Nationwide epidemiologic survey of Kawasaki disease in Japan, 2015-2016. Pediatr Int 61:397\u2013403","journal-title":"Pediatr Int"},{"key":"6792_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","volume":"173","author":"DP Bartel","year":"2018","unstructured":"Bartel DP (2018) Metazoan MicroRNAs. Cell 173:20\u201351","journal-title":"Cell"},{"key":"6792_CR6","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.1038\/sj.emboj.7600385","volume":"23","author":"Y Lee","year":"2004","unstructured":"Lee Y, Kim M, Han J et al (2004) MicroRNA genes are transcribed by RNA polymerase II. EMBO J 23:4051","journal-title":"EMBO J"},{"key":"6792_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature01957","volume":"425","author":"Y Lee","year":"2003","unstructured":"Lee Y, Ahn C, Han J et al (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature 425:415\u2013419","journal-title":"Nature"},{"key":"6792_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1126\/science.1090599","volume":"303","author":"E Lund","year":"2004","unstructured":"Lund E, Guttinger S, Calado A et al (2004) Nuclear export of microRNA precursors. Science 303:95\u201398","journal-title":"Science"},{"key":"6792_CR9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrm3838","volume":"15","author":"M Ha","year":"2014","unstructured":"Ha M, Kim VN (2014) Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 15:509\u2013524","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6792_CR10","doi-asserted-by":"publisher","first-page":"D68","DOI":"10.1093\/nar\/gkt1181","volume":"42","author":"A Kozomara","year":"2013","unstructured":"Kozomara A, Griffiths-Jones S (2013) miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 42:D68\u2013D73","journal-title":"Nucleic Acids Res"},{"key":"6792_CR11","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1093\/nar\/gkz097","volume":"47","author":"J Alles","year":"2019","unstructured":"Alles J, Fehlmann T, Fischer U et al (2019) An estimate of the total number of true human miRNAs. Nucleic Acids Res 47:3353\u20133364","journal-title":"Nucleic Acids Res"},{"key":"6792_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23137167","volume":"23","author":"PT Ho","year":"2022","unstructured":"Ho PT, Clark IM, Le LT (2022) Microrna-based diagnosis and therapy. Int J Mol Sci 23:7167","journal-title":"Int J Mol Sci"},{"key":"6792_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17101712","volume":"17","author":"C Catalanotto","year":"2016","unstructured":"Catalanotto C, Cogoni C, Zardo G (2016) Microrna in control of gene expression: an overview of nuclear functions. Int J Mol Sci 17:1712","journal-title":"Int J Mol Sci"},{"key":"6792_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2013.00119","volume":"4","author":"A Turchinovich","year":"2013","unstructured":"Turchinovich A, Samatov TR, Tonevitsky AG et al (2013) Circulating miRNAs: cell\u2013cell communication function? Front Genet 4:119","journal-title":"Front Genet"},{"key":"6792_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158243","author":"A \u0106wikli\u0144ska","year":"2024","unstructured":"\u0106wikli\u0144ska A, Procyk G, Koziorowski D et al (2024) The role of microRNAs in progressive supranuclear palsy-a systematic review. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25158243","journal-title":"Int J Mol Sci"},{"key":"6792_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232416022","author":"O Grodzka","year":"2022","unstructured":"Grodzka O, Procyk G, G\u0105secka A (2022) The role of microRNAs in myocarditis-what can we learn from clinical trials? Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232416022","journal-title":"Int J Mol Sci"},{"key":"6792_CR17","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.3390\/cimb46020091","volume":"46","author":"O Grodzka","year":"2024","unstructured":"Grodzka O, Procyk G, Wrzosek M (2024) A narrative review of preclinical in vitro studies investigating microRNAs in myocarditis. Curr Issues Mol Biol 46:1413\u20131423","journal-title":"Curr Issues Mol Biol"},{"key":"6792_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116108","author":"K Kie\u0142bowski","year":"2024","unstructured":"Kie\u0142bowski K, Bakinowska E, Procyk G et al (2024) The role of microRNA in the pathogenesis of Duchenne muscular dystrophy. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25116108","journal-title":"Int J Mol Sci"},{"key":"6792_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713095","author":"A Krauze","year":"2023","unstructured":"Krauze A, Procyk G, G\u0105secka A et al (2023) The role of microRNAs in aortic stenosis-lessons from recent clinical research studies. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241713095","journal-title":"Int J Mol Sci"},{"key":"6792_CR20","doi-asserted-by":"publisher","first-page":"436","DOI":"10.33963\/v.phj.104204","volume":"83","author":"A Kuch","year":"2025","unstructured":"Kuch A, Procyk G, Borowiec K et al (2025) The role of MicroRNAs in arrhythmogenic right ventricular cardiomyopathy: a systematic review. Kardiol Pol 83:436\u2013446","journal-title":"Kardiol Pol"},{"key":"6792_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11102723","author":"G Procyk","year":"2023","unstructured":"Procyk G, Grodzka O, Procyk M et al (2023) MicroRNAs in myocarditis-review of the preclinical in vivo trials. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines11102723","journal-title":"Biomedicines"},{"key":"6792_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11071763","author":"G Procyk","year":"2022","unstructured":"Procyk G, Klimczak-Tomaniak D, Sygitowicz G et al (2022) Circulating and platelet microRNAs in cardiovascular risk assessment and antiplatelet therapy monitoring. J Clin Med. https:\/\/doi.org\/10.3390\/jcm11071763","journal-title":"J Clin Med"},{"key":"6792_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1089\/gtmb.2024.0035","volume":"28","author":"E Sapountzi","year":"2024","unstructured":"Sapountzi E, Kotanidou EP, Tsinopoulou VR et al (2024) Kawasaki disease: an update on genetics and pathophysiology. Genet Test Mol Biomarkers 28:373\u2013383","journal-title":"Genet Test Mol Biomarkers"},{"key":"6792_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1016575","volume":"13","author":"Y Xiong","year":"2022","unstructured":"Xiong Y, Xu J, Zhang D et al (2022) Micrornas in Kawasaki disease: an update on diagnosis, therapy and monitoring. Front Immunol 13:1016575","journal-title":"Front Immunol"},{"key":"6792_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.922868","author":"M Guo","year":"2022","unstructured":"Guo M, Fan S, Chen Q et al (2022) Platelet-derived microRNA-223 attenuates TNF-\u03b1 induced monocytes adhesion to arterial endothelium by targeting ICAM-1 in Kawasaki disease. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.922868","journal-title":"Front Immunol"},{"key":"6792_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/srep44706","author":"H Jia","year":"2017","unstructured":"Jia H, Liu C, Zhang L et al (2017) Sets of serum exosomal microRNAs as candidate diagnostic biomarkers for Kawasaki disease. Sci Rep. https:\/\/doi.org\/10.1038\/srep44706","journal-title":"Sci Rep"},{"key":"6792_CR27","doi-asserted-by":"publisher","first-page":"e990","DOI":"10.1002\/mgg3.990","volume":"7","author":"S-C Li","year":"2019","unstructured":"Li S-C, Huang L-H, Chien K-J et al (2019) MiR-182-5p enhances in vitro neutrophil infiltration in Kawasaki disease. Mol Genet Genom Med 7:e990","journal-title":"Mol Genet Genom Med"},{"key":"6792_CR28","first-page":"4181","volume":"12","author":"Y Li","year":"2019","unstructured":"Li Y, Wu X, Gao F et al (2019) MiR-197-3p regulates endothelial cell proliferation and migration by targeting IGF1R and BCL2 in Kawasaki disease. Int J Clin Exp Pathol 12:4181\u20134192","journal-title":"Int J Clin Exp Pathol"},{"key":"6792_CR29","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1007\/s11010-021-04238-7","volume":"476","author":"C Liu","year":"2021","unstructured":"Liu C, Yang D, Wang H et al (2021) MicroRNA-197-3p mediates damage to human coronary artery endothelial cells via targeting TIMP3 in Kawasaki disease. Mol Cell Biochem 476:4245\u20134263","journal-title":"Mol Cell Biochem"},{"key":"6792_CR30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/JLB.5A0919-075RR","volume":"107","author":"Y Luo","year":"2020","unstructured":"Luo Y, Yang J, Zhang C et al (2020) Up-regulation of miR-27a promotes monocyte-mediated inflammatory responses in Kawasaki disease by inhibiting function of B10 cells. J Leukocyte Biol 107:133\u2013144","journal-title":"J Leukocyte Biol"},{"key":"6792_CR31","doi-asserted-by":"publisher","first-page":"9061568","DOI":"10.1155\/2020\/9061568","volume":"2020","author":"Q Ning","year":"2020","unstructured":"Ning Q, Chen L, Song S et al (2020) The platelet microRNA profile of Kawasaki disease: identification of novel diagnostic biomarkers. BioMed Res Int 2020:9061568","journal-title":"BioMed Res Int"},{"key":"6792_CR32","doi-asserted-by":"publisher","unstructured":"Wang X, Ding YY, Chen Y et al (2019) Lv HT MiR-223-3p alleviates vascular endothelial injury by targeting IL6ST in Kawasaki disease. Front Pediatr\u00a07:288.\u00a0https:\/\/doi.org\/10.3389\/fped.2019.00288. Erratum in: Front Pediatr\u00a07:449.\u00a0https:\/\/doi.org\/10.3389\/fped.2019.00449","DOI":"10.3389\/fped.2019.00288"},{"key":"6792_CR33","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/iub.2015","volume":"71","author":"Y Wang","year":"2019","unstructured":"Wang Y, Lian XL, Zhong JY et al (2019) Serum exosomal microRNA let-7i-3p as candidate diagnostic biomarker for Kawasaki disease patients with coronary artery aneurysm. IUBMB Life. 71:891\u2013900","journal-title":"IUBMB Life."},{"key":"6792_CR34","first-page":"1899","volume":"41","author":"R Wu","year":"2018","unstructured":"Wu R, Shen D, Sohun H et al (2018) MiR-186, a serum microRNA, induces endothelial cell apoptosis by targeting SMAD6 in Kawasaki disease. Int J Mol Med 41:1899\u20131908","journal-title":"Int J Mol Med"},{"key":"6792_CR35","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00246-013-0846-6","volume":"35","author":"KW Yun","year":"2014","unstructured":"Yun KW, Lee JY, Yun SW et al (2014) Elevated serum level of microRNA (miRNA)-200c and miRNA-371-5p in children with Kawasaki disease. Pediatr Cardiol 35:745\u2013752","journal-title":"Pediatr Cardiol"},{"key":"6792_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.939","author":"R Zheng","year":"2023","unstructured":"Zheng R, Xie J, Li W et al (2023) MiR-223-3p affects the proliferation and apoptosis of HCAECs in Kawasaki disease by regulating the expression of FOXP3. Immun Inflamm Dis. https:\/\/doi.org\/10.1002\/iid3.939","journal-title":"Immun Inflamm Dis"},{"key":"6792_CR37","doi-asserted-by":"publisher","first-page":"e001625","DOI":"10.1161\/CIRCGENETICS.116.001625","volume":"10","author":"HC Kuo","year":"2017","unstructured":"Kuo HC, Wong HS, Chang WP et al (2017) Prediction for intravenous immunoglobulin resistance by using weighted genetic risk score identified from genome-wide association study in Kawasaki disease. Circ Cardiovasc Genet 10:e001625","journal-title":"Circ Cardiovasc Genet"},{"key":"6792_CR38","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41390-020-1029-9","volume":"92","author":"J Zhao","year":"2022","unstructured":"Zhao J, Chen D (2022) Kawasaki disease: SOCS2-AS1\/miR-324-5p\/CUEDC2 axis regulates the progression of human umbilical vein endothelial cells. Pediatr Res 92:388\u2013395","journal-title":"Pediatr Res"},{"key":"6792_CR39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.21037\/tp-22-7","volume":"11","author":"J Hao","year":"2022","unstructured":"Hao J, Zhang Y, Pan X et al (2022) Kawasaki disease: lncRNA Slco4a1 regulates the progression of human umbilical vein endothelial cells by targeting the miR-335-5p\/POU5F1 axis. Transl Pediatr 11:183\u2013193","journal-title":"Transl Pediatr"},{"key":"6792_CR40","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1161\/CIRCRESAHA.116.310233","volume":"120","author":"M He","year":"2017","unstructured":"He M, Chen Z, Martin M et al (2017) miR-483 targeting of CTGF suppresses endothelial-to-mesenchymal transition: therapeutic implications in Kawasaki disease. Circ Res. 120:354\u2013365","journal-title":"Circ Res."},{"key":"6792_CR41","first-page":"2420","volume":"16","author":"X Zhang","year":"2018","unstructured":"Zhang X, Xin G, Sun D (2018) Serum exosomal miR-328, miR-575, miR-134 and miR-671-5p as potential biomarkers for the diagnosis of Kawasaki disease and the prediction of therapeutic outcomes of intravenous immunoglobulin therapy. Exp Ther Med 16:2420\u20132432","journal-title":"Exp Ther Med"},{"key":"6792_CR42","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.2147\/IDR.S174140","volume":"11","author":"D Che","year":"2018","unstructured":"Che D, Li J, Fu L et al (2018) The rs1625579 T>G polymorphism in the miRNA-137 gene confers a risk of early-onset Kawasaki disease in a Southern Chinese population. Infect Drug Resis 11:1055\u20131060","journal-title":"Infect Drug Resis"},{"key":"6792_CR43","doi-asserted-by":"crossref","unstructured":"Chen C-C, Chu H-Y, Chang IY-F et al (2024) Symptom-correlated MiRNA signature as a potential biomarker for Kawasaki disease. Biomed J 47:100684","DOI":"10.1016\/j.bj.2023.100684"},{"key":"6792_CR44","first-page":"932","volume":"17","author":"Y Chen","year":"2018","unstructured":"Chen Y, Ding Y, Ren Y et al (2018) Identification of differentially expressed MicroRNAs in acute Kawasaki disease. Mol Med Rep 17:932\u2013938","journal-title":"Mol Med Rep"},{"key":"6792_CR45","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004878","author":"M Chu","year":"2017","unstructured":"Chu M, Wu R, Qin S et al (2017) Bone marrow-derived microRNA-223 works as an endocrine genetic signal in vascular endothelial cells and participates in vascular injury from Kawasaki disease. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.116.004878","journal-title":"J Am Heart Assoc"},{"key":"6792_CR46","doi-asserted-by":"publisher","unstructured":"Fu L, Xu Y, Yu H et al (2022) Association study of miR-149, miR-196a2, and miR-499a polymorphisms with coronary artery aneurysm of Kawasaki disease in southern Chinese population. J Gene Med 24(4):e3405. https:\/\/doi.org\/10.1002\/jgm.3405","DOI":"10.1002\/jgm.3405"},{"key":"6792_CR47","doi-asserted-by":"publisher","unstructured":"Huang X, Li H, Zhao X et al (2025) Combination of CRP and miRNA signature as a potential diagnostic strategy for Kawasaki disease. Front Pediatr 13:1678095. https:\/\/doi.org\/10.3389\/fped.2025.1678095","DOI":"10.3389\/fped.2025.1678095"},{"key":"6792_CR48","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s10238-021-00776-y","volume":"22","author":"F Jing","year":"2022","unstructured":"Jing F, Weng H, Pei Q et al (2022) Association between serum miR-221-3p and intravenous immunoglobulin resistance in children with Kawasaki disease. Clin Exp Med 22:621\u2013628","journal-title":"Clin Exp Med"},{"key":"6792_CR49","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.yjmcc.2020.06.011","volume":"146","author":"P-N Jone","year":"2020","unstructured":"Jone P-N, Korst A, Karimpour-Fard A et al (2020) Circulating microRNAs differentiate Kawasaki disease from infectious febrile illnesses in childhood. J Mol Cell Cardiol 146:12\u201318","journal-title":"J Mol Cell Cardiol"},{"key":"6792_CR50","doi-asserted-by":"publisher","unstructured":"Li J, Wang J, Su X, Jiang Z, Rong X, Gu X, Jia C, Zeng L, Zheng H, Gu X, Chu M (2020) Association between the miRNA-149 rs2292832 T>C polymorphism and Kawasaki disease susceptibility in a southern Chinese population. J Clin Lab Anal 34(4):e23125. https:\/\/doi.org\/10.1002\/jcla.23125. Epub 2019 Nov 29","DOI":"10.1002\/jcla.23125"},{"key":"6792_CR51","first-page":"7820","volume":"14","author":"X Li","year":"2022","unstructured":"Li X, Sun Y, Cai Y et al (2022) Identification of miRNA profile in the peripheral blood and clinical significance of miR-355 and miR-2911 expression in children with Kawasaki disease. Am J Transl Research. 14:7820\u20137830","journal-title":"Am J Transl Research."},{"key":"6792_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175407","author":"Z Li","year":"2017","unstructured":"Li Z, Jiang J, Tian L et al (2017) A plasma miR-125a-5p as a novel biomarker for Kawasaki disease and induces apoptosis in HUVECs. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0175407","journal-title":"PLoS One"},{"key":"6792_CR53","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1080\/08820139.2021.1877302","volume":"51","author":"Y Luo","year":"2022","unstructured":"Luo Y, Yu M, Li P et al (2022) The expression and role of microRNA-133a in plasma of patients with Kawasaki disease. Immunol Investig 51:826\u2013838","journal-title":"Immunol Investig"},{"key":"6792_CR54","first-page":"11222","volume":"24","author":"HF Lv","year":"2020","unstructured":"Lv HF, Sun XQ, Zhou HX et al (2020) Diagnostic value of miRNA-122 in Kawasaki disease. Eur Rev Med Pharmacol Sci 24:11222\u201311226","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"6792_CR55","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/s41598-018-19310-4","volume":"8","author":"H Nakaoka","year":"2018","unstructured":"Nakaoka H, Hirono K, Yamamoto S et al (2018) MicroRNA-145-5p and microRNA-320a encapsulated in endothelial microparticles contribute to the progression of vasculitis in acute Kawasaki disease. Sci Rep 8:1016","journal-title":"Sci Rep"},{"key":"6792_CR56","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/cei.12418","volume":"178","author":"FF Ni","year":"2014","unstructured":"Ni FF, Li C, Li Q et al (2014) Regulatory T cell microRNA expression changes in children with acute Kawasaki disease. Clin Exp Immunol 178:384\u2013393","journal-title":"Clin Exp Immunol"},{"key":"6792_CR57","doi-asserted-by":"publisher","unstructured":"Pi L, Fu L, Xu Y et al (2018)\u00a0Lack of association between miR-218 rs11134527 A>G and Kawasaki disease susceptibility. Biosci Rep 38(3):BSR20180367. https:\/\/doi.org\/10.1042\/BSR20180367","DOI":"10.1042\/BSR20180367"},{"key":"6792_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.imu.2020.100423","author":"Y Rahmati","year":"2020","unstructured":"Rahmati Y, Mollanoori H, Kakavandi N et al (2020) Gene expression analysis in Kawasaki disease; bioinformatics and experimental approach. Inform Med Unlocked. https:\/\/doi.org\/10.1016\/j.imu.2020.100423","journal-title":"Inform Med Unlocked"},{"key":"6792_CR59","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1159\/000492354","volume":"48","author":"X Rong","year":"2018","unstructured":"Rong X, Ge D, Shen D et al (2018) MiR-27b suppresses endothelial cell proliferation and migration by targeting Smad7 in Kawasaki disease. Cell Physiol Biochem 48:1804\u20131814","journal-title":"Cell Physiol Biochem"},{"key":"6792_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12265-016-9717-x","volume":"10","author":"X Rong","year":"2017","unstructured":"Rong X, Jia L, Hong L et al (2017) Serum miR-92a-3p as a new potential biomarker for diagnosis of Kawasaki disease with coronary artery lesions. J Cardiovasc Transl Res 10:1\u20138","journal-title":"J Cardiovasc Transl Res"},{"key":"6792_CR61","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1097\/INF.0000000000000449","volume":"33","author":"AH Rowley","year":"2014","unstructured":"Rowley AH, Pink AJ, Reindel R et al (2014) A study of cardiovascular miRNA biomarkers for Kawasaki disease. Pediatr Infect Dis J 33:1296\u20131299","journal-title":"Pediatr Infect Dis J"},{"key":"6792_CR62","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/pr.2016.93","volume":"80","author":"K Saito","year":"2016","unstructured":"Saito K, Nakaoka H, Takasaki I et al (2016) MicroRNA-93 may control vascular endothelial growth factor A in circulating peripheral blood mononuclear cells in acute Kawasaki disease. Pediatr Res 80:425\u2013432","journal-title":"Pediatr Res"},{"key":"6792_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058159","author":"C Shimizu","year":"2013","unstructured":"Shimizu C, Kim J, Stepanowsky P et al (2013) Differential expression of miR-145 in children with Kawasaki disease. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0058159","journal-title":"PLoS One"},{"key":"6792_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00237","volume":"7","author":"B Wang","year":"2019","unstructured":"Wang B, Wang L-N, Cheng F-F et al (2019) MiR-222-3p in platelets serves as a distinguishing marker for early recognition of Kawasaki disease. Front Pediatr 7:237","journal-title":"Front Pediatr"},{"key":"6792_CR65","doi-asserted-by":"publisher","unstructured":"Wang J, Li J, Qiu H et al (2019) Association between miRNA-196a2 rs11614913 T>C polymorphism and Kawasaki disease susceptibility in southern Chinese children. J Clin Lab Anal 33(7):e22925. https:\/\/doi.org\/10.1002\/jcla.22925. Epub 2019 May 26.","DOI":"10.1002\/jcla.22925"},{"key":"6792_CR66","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.9593","author":"Y Wang","year":"2020","unstructured":"Wang Y, Li C, Niu L et al (2020) Difference in serum miRNA expression between immunoglobulin-sensitive and -insensitive incomplete Kawasaki disease patients. Exp Ther Med. https:\/\/doi.org\/10.3892\/etm.2020.9593","journal-title":"Exp Ther Med"},{"key":"6792_CR67","doi-asserted-by":"publisher","unstructured":"Wang Y, Lu Z, Fu L et al (2019) The miRNA-608 rs4919510 G>C polymorphism confers reduce coronary injury of Kawasaki disease in a Southern Chinese population. Biosci Rep 39(5):BSR20181660. https:\/\/doi.org\/10.1042\/BSR20181660","DOI":"10.1042\/BSR20181660"},{"key":"6792_CR68","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1017\/S1047951124036230","volume":"35","author":"Y-E Wang","year":"2025","unstructured":"Wang Y-E, Sun D-Q, Hu H-Z (2025) Urinary exosomal microRNA-200 family: diagnostic biomarkers for Kawasaki disease and their link to inflammatory markers. Cardiol Young 35:324\u2013331","journal-title":"Cardiol Young"},{"key":"6792_CR69","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.7754\/Clin.Lab.2019.190507","volume":"65","author":"Z Wang","year":"2019","unstructured":"Wang Z, Zhou J, Dong N et al (2019) Diagnostic significance of MIR-937 in peripheral blood mononuclear cells of Kawasaki disease. Clin Lab 65:2157\u20132163","journal-title":"Clin Lab"},{"key":"6792_CR70","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/cimb43020037","volume":"43","author":"K-P Weng","year":"2021","unstructured":"Weng K-P, Cheng C-F, Chien K-J et al (2021) Identifying circulating microRNA in Kawasaki disease by next-generation sequencing approach. Curr Issues Mol Biol 43:485\u2013500","journal-title":"Curr Issues Mol Biol"},{"key":"6792_CR71","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.7754\/Clin.Lab.2019.190339","volume":"65","author":"J Yan","year":"2019","unstructured":"Yan J, Wang H, Gao L (2019) Diagnostic value of serum miR-1 in patients with acute Kawasaki disease. Clin Lab 65:1339\u20131344","journal-title":"Clin Lab"},{"key":"6792_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.899779","author":"M Yao","year":"2022","unstructured":"Yao M, He Q, Yang M et al (2022) Association of miR-181c\/d gene locus rs8108402 C\/T polymorphism with susceptibility to Kawasaki disease in Chinese children. Front Pediatr. https:\/\/doi.org\/10.3389\/fped.2022.899779","journal-title":"Front Pediatr"},{"key":"6792_CR73","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s00246-018-2002-9","volume":"40","author":"L Zha","year":"2019","unstructured":"Zha L, Li S, Liu X et al (2019) Association of miR-146a gene polymorphism at loci rs2910164 G\/C, rs57095329 A\/G, and rs6864584 T\/C with susceptibility to Kawasaki disease in Chinese children. Pediatr Cardiol 40:504\u2013512","journal-title":"Pediatr Cardiol"},{"key":"6792_CR74","doi-asserted-by":"publisher","unstructured":"Zhang L, Wang J, Che D et al (2018) The association between the miR-146a rs2910164 C>G polymorphism and Kawasaki disease in a southern Chinese population. Biosci Rep 38(4):BSR20180749. https:\/\/doi.org\/10.1042\/BSR20180749","DOI":"10.1042\/BSR20180749"},{"key":"6792_CR75","first-page":"12757","volume":"24","author":"R Zhang","year":"2020","unstructured":"Zhang R, Wu L, Zhang HJ et al (2020) Expression levels of plasma miRNA-21 and NT-proBNP in children with Kawasaki disease and their clinical significance. Eur Rev Med Pharm Sci 24:12757\u201312762","journal-title":"Eur Rev Med Pharm Sci"},{"key":"6792_CR76","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8257862","author":"W Zhang","year":"2017","unstructured":"Zhang W, Wang Y, Zeng Y et al (2017) Serum miR-200c and miR-371-5p as the useful diagnostic biomarkers and therapeutic targets in Kawasaki disease. Biomed Res Int. https:\/\/doi.org\/10.1155\/2017\/8257862","journal-title":"Biomed Res Int"},{"key":"6792_CR77","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1161\/CIRCRESAHA.120.316951","volume":"127","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wang Y, Zhang L et al (2020) Reduced platelet miR-223 induction in Kawasaki disease leads to severe coronary artery pathology through a miR-223\/PDGFR\u00df vascular smooth muscle cell axis. Circ Res 127:855\u2013873","journal-title":"Circ Res"},{"key":"6792_CR78","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.cell.2007.04.040","volume":"129","author":"P Landgraf","year":"2007","unstructured":"Landgraf P, Rusu M, Sheridan R et al (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129:1401\u20131414","journal-title":"Cell"},{"key":"6792_CR79","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1111\/j.1582-4934.2008.00585.x","volume":"13","author":"J-Y Yuan","year":"2009","unstructured":"Yuan J-Y, Wang F, Yu J et al (2009) MicroRNA-223 reversibly regulates erythroid and megakaryocytic differentiation of K562 cells. J Cell Mol Med 13:4551\u20134559","journal-title":"J Cell Mol Med"},{"key":"6792_CR80","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1158\/1940-6207.CAPR-23-0156","volume":"17","author":"S Alimena","year":"2024","unstructured":"Alimena S, Stephenson BJK, Webber JW et al (2024) Differences in serum miRNA profiles by race, ethnicity, and socioeconomic status: implications for developing an equitable ovarian cancer screening test. Cancer Prev Res 17:177\u2013185","journal-title":"Cancer Prev Res"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-06792-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-06792-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-06792-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T09:03:44Z","timestamp":1776935024000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-06792-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":80,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["6792"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-06792-y","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The manuscript does not contain clinical studies or patient data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The protocol for this review was not prepared, and the review was not registered.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Registration and protocol"}}],"article-number":"137"}}